...
首页> 外文期刊>Lab on a chip >A radial microfluidic platform for higher throughput chemotaxis studies with individual gradient control
【24h】

A radial microfluidic platform for higher throughput chemotaxis studies with individual gradient control

机译:具有个体梯度控制的高通量趋化性研究的径向微流体平台

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chemotaxis plays a fundamental role in immune defense and cancer metastasis. Microfluidic devices are increasingly applied to studying chemotaxis, owing to their advantages of reduced reagent consumption, ability to control chemical gradients, tracking of individual cells, and quantification of chemotaxis. Many existing microfluidic chemotaxis devices suffer from limited throughput and complex operation. Here, we describe a microfluidic device with a radial channel design which allows for simultaneous chemotaxis tests of different cell types and different gradient conditions. This radial microfluidic device was capable of stand-alone stable gradient generation using passive pumping and pressure-balancing strategies. The device was validated by testing the migration of fast-migrating human neutrophils and two slower-migrating human breast cancer cell lines, MDA-MB-231 and MCF-7 cells. Furthermore, this radial microfluidic device was useful in studying the influence of the nuclear chromatin binding protein high mobility group A2 (HMGA2) on the migration of the human triple negative breast cancer cell line MDA-MB-231.
机译:趋化性在免疫防御和癌症转移中起着基本作用。由于它们的优点,微流体装置越来越多地应用于研究趋化性,因此减少了试剂的优点,控制化学梯度,跟踪单个细胞的跟踪和趋化性的能力。许多现有的微流体趋化性装置患有有限的产量和复杂的操作。这里,我们描述一种具有径向通道设计的微流体装置,其允许同时进行不同细胞类型和不同梯度条件的趋化性测试。这种径向微流体装置能够使用被动泵送和压力平衡策略进行独立的稳定梯度。通过测试快速迁移的人性化学粒细胞的迁移和两次较慢迁移的人乳腺癌细胞系,MDA-MB-231和MCF-7细胞来验证该装置。此外,这种径向微流体装置可用于研究核染色质结合蛋白高迁移率组A2(HMGA2)对人三阴性乳腺癌细胞系MDA-MB-231的迁移的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号